chrisvoncsefalvay/vaers-outcomes huggingface dataset:
3 pt's were given doses of Plague vax (the last few in the vial); w/in approx 45-60 minutes the pt's exp weakness, lightheadedness, & 1 w/low grade fever; All examined & given sick in quarters for 24hrs;
Slight fever, bumps/rash on entire body, swelling in the arms and hands, pain in the fingers of the arm where vaccine was given.
This patient experienced rash on the arms and back 7 hours after the injection. He also experienced general malaise at first which progressed to severe arthralgia and swelling of the joints within 3 days.
Red blanching annular lesions on legs, chest, hands, buttocks - started at vaccine site.
Presents to emergency department with complaints of intermittent chest pain for 4 days.  Denies any radiation of his chest pain.  He also complains of having leg weakness with trying to stand or ambulate x4 days.  States that his legs feel like "gummy".  Wife notes that the patient has to hold onto objects to aid in ambulation which is not normal for him.  The patient denies any headache or dizziness.  He denies any acute vision changes.  He denies any numbness or tingling to his lower extremities.  Denies any history of stroke.
Pt had hive like rash Hives vs. Erethyma Multiforme
am in a lot of pain; migraine headache; This is a spontaneous report from a contactable consumer (patient). A 74-years-old female patient received bnt162b2 (BNT162B2, Pfizer-BioNTech Covid-19 mRNA Vaccine, Solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on 18Jan2021 as DOSE 1, SINGLE for COVID -19 immunization. The patient medical history and concomitant medications were not reported. The patient was given her first dose of the pfizer covid vaccine 3 weeks ago. She was supposed to get the second dose of the vaccine yesterday but was unable to because she was being quarantined after going to an appointment outside of the facility. She was told that the next time they can provide her with the second dose will be 01Mar2021. On an unspecified date, patient was in a lot of pain and migraine headache. She wants to know if she can safely receive the second dose this far apart from the first. No PQC Present.  She was really upset that she was not given the shot and they kept telling her that they were on their way and then they told the nurse that they will be back for first dose next month which just means she was going to be quarantined in her room longer, three weeks longer. Right now, she got a migraine headache and she can't even talk about it." The outcome for all the events was unknown.  Information about lot/batch number has been requested.  Follow-up attempts are completed. No further information is expected.
Pt vaccinated with DTP/OPV/MMR/HIB became irritable, crying, wheezing, fever 101, Taken to ER; breathing was stabilized transferred to another hosp dx bronchiolitis not believed to be vaccine related.
Eight days later swelling, redness, hot welt like rash at injection site. Seems to be getting bigger. About 4 inches in diameter.
Information has been received from a nurse concerning her 17 year old daughter who in 1996 was vaccinated with a dose of varicella virus vaccine live. Subsequently, the pt developed chicken pox. On 13Apr04 the pt began to develop lesions described as a rash mainly on the torso with 100 total lesions, perhaps 50 on the front and 50 on her back. She also had a very low grade fever of about 99 degrees. She missed school for one week, but now has recovered and is doing well. No treatment or doctor visit was necessary. No product quality complaint was involved. No additional information is expected.
This case was reported by a other health professional via call center representative and described the occurrence of allergic reaction in a 57-year-old female patient who received BOOSTRIX (batch number 2774D, expiry date 9th March 2021) for prophylaxis. On 5th December 2018, the patient received BOOSTRIX. On 8th December 2018, 3 days after receiving BOOSTRIX, the patient experienced allergic reaction. On an unknown date, the outcome of the allergic reaction was unknown. It was unknown if the reporter considered the allergic reaction to be related to BOOSTRIX. Additional details were reported as follows: The healthcare professional (HCP) states patient complained of an allergic reaction on her arm 3 days after receiving a BOOSTRIX vaccine. The HCP had no further information on this adverse event and did not want to be contacted regarding this adverse event. The reporter did not consent to follow up.
Patient is 17 years old who received dose 1 of Moderna vaccine on 25Mar2021; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Patient is 17 years old who received dose 1 of Moderna vaccine on 25Mar2021) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Patient is 17 years old who received dose 1 of Moderna vaccine on 25Mar2021). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Patient is 17 years old who received dose 1 of Moderna vaccine on 25Mar2021) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication were reported. No treatment information was provided.
Approximately 1 hour after her shot, this patient's arm developed stiffness, and soreness. By 4 hours, extremely stiff and sore, involving entire left deltoid region (Sternum - backbone) and part of the left side below. Approximately 5 hours after, the patient had a period of moderately tight chest and shortness of breath, some dizziness, stiffness and pain persisted all night; now resolving.
Paresthesia, numbness, tingling from top of right shoulder extending down to right 5 fingers. Htn, Tachycardia.
Vaccine administered after more than 1 temperature excursion; Vaccine administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Feb-2021 at 2:39 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 17-Feb-2021 at 2:39 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion). In 2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was provided as 76.05.  Concomitant products were not provided.  On 17-Feb-2021, Excursion time was 09 AM, temperature was 22, total doses given for the day was 62, condition of vaccine prior to administration was not frozen, vaccine was moved to fridge on 11-Feb-2021, vial was moved to clinic on 17-Feb-2021. 5 vials were sent to clinic. Vaccine BUD date was 31-Mar-2021.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic.  Temperature recordings were taken using a Fisher brand traceable temperature monitor at every hour.  After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature.  It was reported that the patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks in 2021. The HCP explained that each time a vial was put into a cooler, there was a period of 1 hour or 1 and half hour approximately, when the temperature data logger registered 34 or 35 degree F.  Treatment medications were not reported.
Sore arm after first shot; Very low fever after first shot; Headache after first shot; Fatigue after first shot; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm after first shot), PYREXIA (Very low fever after first shot), HEADACHE (Headache after first shot) and FATIGUE (Fatigue after first shot) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm after first shot), PYREXIA (Very low fever after first shot), HEADACHE (Headache after first shot) and FATIGUE (Fatigue after first shot). On 15-Feb-2021, PAIN IN EXTREMITY (Sore arm after first shot), PYREXIA (Very low fever after first shot), HEADACHE (Headache after first shot) and FATIGUE (Fatigue after first shot) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No concomitant product reported by reporter. No treatment medication reported by reporter.   This case was linked to MOD-2021-372412, MOD-2021-372413 (Patient Link).
Pt reports no adverse events  - patient received 0.5ml dose instead of 0.3ml dose
My entire life I have been very active, worked out every day of my life since 15, never ever in my life had any sort of acne...no health problems.  About a year ago everything changed, in the past year I have gained exactly 27 pounds and although I continue and try to workout I am unable to lose this weight...I am so fatigued to the point I cant get out of bed most days which has affected a few semesters of college and I have lost a few jobs due to this fatigue which I cannot control.  I am unable to bend over and pick anything up without getting dizzy and any activity as simple as running up the stairs my heart speeds up and I am out of breath and need to sit. I have consistently had a minimum of 2 migraines a week in which I am unable to leave the house this has been for the past year, and prior to these migraines I have extreme back and neck pain which painkillers cannot even help.  I have been to numerous dermatologists trying to resolve 2 issues, adult acne AND excessive facial hair growth on my jawline, chin and under chin to the point Ii just use a razor now to remove the hair as I am unable to afford full laser hair removal and insurance does not cover.  My entire life I have had beautiful thick hair, in fact so thick I would get stopped by people with compliments however the past year I pull chucks of hair out in the shower and it is very thin and brittle now.  I have done so much blood work and every test in the book.  In the past year I have been to a heart doctor, dermatologists, chiropractors, endocrinologist, natural homeopathic doctor, and 3 different physicians and NO ONE has a solution...my mom has been very down as she is upset for me and with me we feel so lost nobody has any idea what is going on.  The past year I have consistently described myself as "this is not me and this is not my body".  I now get depressed as I have no control of the weight gain or acne or facial hair or hair loss or any of this.  My numerous doctor visits and mental pain I have endured have left a hole in my family's wallet and in my spirit.
Patient called pharmacy day of vaccination stating that her arm hurt. She came into the pharmacy on 11/14 stating that her arm still hurt and she was experiencing tendonitis which hurt worse than labor pains. She stated that she went to the emergency room and the doctor there told her that the vaccine must've been given too high up. She went to her primary care doctor and he/she also told her the same thing.
Strange/metallic taste in mouth within 10 minutes of administration.  Lessened by 24 hours post administration; resolved by 60 hours.
TINGLING SENSATION OF FINGERS; MUSCLE CRAMPS; NUMBNESS ON BIG TOES ON LEFT SIDE; JOINTS PAIN; MILD HEADACHE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on MAY-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On MAY-2021, the subject experienced tingling sensation of fingers. On MAY-2021, the subject experienced muscle cramps. On MAY-2021, the subject experienced numbness on big toes on left side. On MAY-2021, the subject experienced joints pain. On MAY-2021, the subject experienced mild headache. Laboratory data (dates unspecified) included: Blood test (NR: not provided) Normal. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from tingling sensation of fingers, mild headache, muscle cramps, joints pain, and numbness on big toes on left side. This report was non-serious.
extremely tired; very sore arm; fever that evening (under 101 F); joint/muscle aching (increased on same side of shot administration); head ache following day felt worse than day of administration - could not move head forward/back or side to side without "terrible pain".  Felt completely "dragged out".  Nausea on following day of administration.
Sore arm when extending; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm when extending) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     Concomitant products included CALCIUM for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm when extending). At the time of the report, PAIN IN EXTREMITY (Sore arm when extending) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment information provided
4/26/05 Presented in office with rash for 2 days. Diagnosed with chicken pox (vaccine failure).
This initial spontaneous case was received from other non-health care professional on 16-Nov-2017, concerning a female patient of unspecified age. The patient had a current condition of asthma since an unspecified date. The patient was not administered with any concomitant vaccines. On an unspecified date, 4 years ago the patient was administered influenza vaccine (anatomical location: arm, dose: reported as full dose, route of administration, trade name, manufacturer, batch number and expiry date: not reported). On an unspecified date, soon after vaccination, the patient experienced hoarse voice as if one had laryngitis. It was reported as 2 weeks afterward the patient recovered from the events. The reporter considered this report as non-serious.
Patient felt slight dizziness about 2 minutes after vaccine. About 8 minutes after his vaccine, he came to the pharmacy counter and almost passed out - he was dizzy and sweating.  He felt better after about 40 minutes of resting (and water and protein bar).
Information has been received from a registered nurse concerning a patient who was vaccinated with pneumococcal 23v polysaccharide vaccine (Lot#650453/0791P).  Subsequently the patient had a reaction to the pneumococcal 23v polysaccharide vaccine.  At the time of the report, it was unknown, if the patient recovered.  The registered nurse reported that another patient received pneumococcal 23v polysaccharide with the same (Lot#650453/0791P) and had a reaction.  A lot check of concern has been requested.  The records of testing prior to release of this lot have been checked by Quality Assurance and found to be satisfactory.  The lot complies with the standards and was released.  In addition, a review of the Quality Control Quarantines/Rejection System revealed that there were no open Quarantines registered against this lot/fill.  Additional information has been requested.
pt recv vax 24SEP96 & pt devel high fever;25SEP96 pt devel rash;
Pt received Pfizer vaccines on 05/01/2021 and 05/25/2021. Pt presented to the ED on 11/25/2021 with complaints of AMS, flu-like symptoms, and hypoxia. Pt was found to be COVID positive and requiring supplemental oxygen.
Information has been received from a pharmacist regarding a 72 years old female patient. The patient's medical history, concurrent condition and concomitant therapy were not reported. On 08-AUG-2018, the patient was administered PREVNAR 13 (strength, dose, frequency, route of administration, lot#, expiration date and indication were not reported). On 08-OCT-2018, the patient was administered PNEUMOVAX 23 (lot# R018735, expiration date 06-APR-2020; strength, dose, frequency and route of administration were not reported) for prophylaxis (product use issue). No adverse effects was reported.
On 02/11/2023, at 08:30AM, I had been feeling lousy. I had headache, fever, sore throat, low energy. I took the COVID-19 home test and it was positive. I contacted a HCP, who gave me PAXLOVID and cough medicine. The next day, the symptoms were more manageable. On Thursday, I tested negative.
Having severe pain at injection site.  Patient is unable to sleep due to pain.  Patient is currently being prescribed hydrocodone.
Patient received injection in right deltoid on 8/28/18 and complained of pain and inflammation approx. two days later on opposite arm. She visited an immedi center that told her to take a NSAI and apply heat to the site. She came to the pharmacy (where she received the injection) to inform us of the situation on 9/3/2018 and again on 9/5/2018 to inform us that all of her symptoms resolved.
This spontaneous report as received from a registered nurse refers to a patient of unknown demography. Patient's concurrent conditions and relevant medical history was not reported. On 07-JAN-2015, the patient was vaccinated with improperly stored PROQUAD (dose, frequency and route unspecified) (lot number: K011314 with expiry date of 14-FEB-2016). Concomitant medications were not reported. The reporter stated that, between 07-JAN-2015 through 19-FEB-2015, PROQUAD was exposed to 34.4 Fahrenheit temperature which was outside the recommended condition. No adverse effects were reported. The outcome of the events was unknown. The causality of the events with PROQUAD was not reported. Product quality issue was not involved. This is one of the several reports from the same reporter. Additional information has been requested.
This spontaneous report was received from a nurse regarding an unspecified number of patients of unknown age and gender. Information on the concurrent conditions and medical history of the patients were not reported. On unspecified dates, the patients were vaccinated with improperly stored ZOSTAVAX lot# L021612, expiry date, 10-SEP-2016. Concomitant medication were not reported. No adverse event were reported. There were no Product Quality Complaint (PQC) involved. Temperature at which the vaccine was stored was 6.5 degree Centigrade, for a time frame of 3 hours. There were no previous temperature excursion. This is one of the several reports from the same reporter. Additional information has been requested.
Immediately following injection of MMR 2 small hives appeared on (L) thigh at site and then 2 small hives on Rt thigh near varicella vaccine BENADRYL po given & resolved.
Developed urticaria rash generalized over arms, hands, lower extremities and trunk. She received vax at 9:00 am and reaction occurred at 9:00 pm same day
Patient complaint of red swollen arm at injection site that is unsually warm to the touch and more painful than expected.
Information has been received from a registered nurse concerning a 45 year old white male with a penicillin allergy who on 5/17/01, at 14:30, was vaccinated SC in the right leg with the first dose of varicella virus vaccine live (lot # 635948/1333K). There was no illness at the time of vaccination. The RN reported that on 2/27/04, the patient developed a rash, itching and fever. It was unknown if medical attention was sought. At the time of this report, the outcoe was unknown. Additional information has been requested.
Right arm pain, BP 135/78, pulse 100, 100% O2 sat.
4/22/2022- AMS with weakness, from SNF, T-99, BP-141/77. Covid + test. CT Head- no eveidenc of intracranial hemorrhage. CXR-scattered calcified granulomas within lungs again notes. Admit AMS s/t Covid-19. Started bebtelovimab and doxy. Currently on 2L NC. 4/24/2022- Spo2 94% on RA. Afebrile. CMP and CBC unremarkable. 4/26/2022 D/C to Assisted living. Afebrile and BP-122/82.
This is a spontaneous report from a contactable physician via a Pfizer sales representative. This physician reported similar events for two patients. This is the second of two reports. An infant patient of an unspecified age (below 2 year-old), race, ethnicity and gender received PREVNAR 13 at single dose via an unspecified route of administration on an unspecified date for immunization. The patient was fully vaccinated (unspecified number of vaccine doses). The patient medical history and concomitant medications were not reported. No underlying health conditions were present. The patient experienced recurrent pneumonia on an unspecified date. When antibody titers were tested , 6-7 of titers were below normal. Outcome was unknown. No follow-up attempts are possible, information about batch number cannot be obtained. Sender's Comments: Based on the information currently available, a lack of efficacy with pneumococcal 13-valent conjugate vaccine in this patient cannot be completely excluded. Linked Report(s): US-PFIZER INC-2017514614 same reporter/suspect product/event, different patient.